BTG International, Inc.
$1.2M 757 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Organ Recovery Systems, Inc.
Organ Recovery Systems, Inc. reported $1,181,143.98 across General Payments, Research, and Ownership to 84 physicians and teaching hospitals across 97 transactions.
- $1.2M Above-median payer
- All-tracks total
- 97 Below-median volume
- Transactions
- 84 Below-median reach
- Recipients
- +$180.7K
- General Payments vs PY2023
Organ Recovery Systems, Inc. reported $1,181,143.98 across all CMS Open Payments tracks (General + Research + Ownership) to 84 physicians and teaching hospitals in Program Year 2024 - ranking #585 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $356,676.02, averaging $14.1K per recipient.
How Organ Recovery Systems, Inc.'s $1.2M all-tracks total breaks down
Organ Recovery Systems, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
21/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer organ-recovery-systems-inc Organ Recovery Systems, Inc.
$1.2M · #585/1,925 · 0.0% industry · PY2024
- TOT $1.2M
- RANK #585
- SHARE 0.0%
- TXN 97
- RCP 84
- CAT 3
- GEN $356.7K
- ΔGEN +$180.7K
- TOP1 41.8%
- PY 2024
Volume peers
Nearest volume peer: BTG International, Inc. ($1.2M)
Organ Recovery Systems, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Organ Recovery Systems, Inc.'s CMS-reported General Payments increased by $180.7K (+102.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ORGAN RECOVERY SYSTEMS, INC.PY2023: ORGAN RECOVERY SYSTEMS, INC.PY2024: Organ Recovery Systems, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $175,949.30
- PY2024
- $356,676.02
What the Data Shows for Organ Recovery Systems, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Organ Recovery Systems, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $211.7K across 23 transactions, 59.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Organ Recovery Systems, Inc.'s 3-category general-payment breakdown at $211.7K, 59.3% of the reported total.
How Organ Recovery Systems, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $211.7K | 23 | 59.3% |
| Space Rental or Facility Fees | $136.6K | 12 | 38.3% |
| Food and Beverage | $8.4K | 49 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $352,730.97 (98.9%) of $356,676.02 in this company's General Payments records across 17 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Organ Recovery Systems, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
James Vincent Guarrera MD
$149,137.85 across 32 reported transactions
- 2
Uh - University Hospital
$136,600.00 across 12 reported transactions
- 3
Ralph Cutler Quillin Md
$47,860.31 across 18 reported transactions
- 4
David C Mulligan Md
$18,400.00 across 1 reported transactions
- 5
Paulo Martins M.D, PhD, FAST, FACS
$732.81 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Organ Recovery Systems, Inc.'s spend rank (#585 of 1,925, top 30% by spend) and concentration rank (#517 of 1,838, top 28% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Datascope Corp. : $1.6M total payments, HHI 3460
- Bristol Myers Squibb Company : $1.0M total payments, HHI 3447
- Collegium Pharmaceutical, Inc. : $1.5M total payments, HHI 3442
- Granata Bio Corporation : $5.5K total payments, HHI 3437
- American Rheumatology Network, LLC : $2.8M total payments, HHI 3431
- Biocircuit Technologies Inc : $69.8K total payments, HHI 3424
- Organ Recovery Systems, Inc. (this company) : $356.7K total payments, HHI 3422
- Omniscient Neurotechnology America Ltd : $73.2K total payments, HHI 3397
- FlexDex Inc. : $350.51 total payments, HHI 3376
- Seres Therapeutics, Inc. : $132.4K total payments, HHI 3375
- Orthopedic Sciences, Inc. : $4.0K total payments, HHI 3369
- L&k Biomed Co. , Ltd. : $864.8K total payments, HHI 3358
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Organ Recovery Systems, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Organ Recovery Systems, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Organ Recovery Systems, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
DiaSorin Inc.
$1.2M 37 recipients
Compare payment profiles
Catalyst Pharmaceuticals, Inc.
$1.2M 8,453 recipients
Compare payment profiles
GenBioPro, Inc.
$1.2M 15 recipients
Compare payment profiles
The North Carolina Mutual Wholesale Drug Company Inc
$1.2M 0 recipients
Compare payment profiles
New Wave Endo-Surgical Corp.
$1.2M 1 recipients
Compare payment profiles
Put this to use
Organ Recovery Systems, Inc. ranks #585 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Organ Recovery Systems, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Organ Recovery Systems, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.